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DEAR EDITOR, Germline mutations in the oncogene HRAS cause
syndromes with systemic and cutaneous features, notably
Costello syndrome (CS).1 Postzygotic activating mutations in
HRAS are increasingly recognized as a cause of epidermal naevi
that are sometimes associated with the extracutaneous features
of germline rasopathies. Epidermal naevi caused by HRAS
mutations present with varied morphology including seba-
ceous naevus, woolly hair naevus and phacomatosis pigmen-
tokeratotica (PPK).2
PPK is characterized by the association of epidermal naevus
with speckled lentiginous naevus of the papular type or papu-
lar naevus spilus. To some extent these localized epidermal
phenotypes correspond to the more generalized cutaneous fea-
tures of CS, namely acanthosis nigricans, papillomas and curly
hair. Pigmented patches and increased numbers of melanocytic
naevi also occur in CS3 but are more characteristic of another
RASopathy, cardiofaciocutaneous syndrome, caused by BRAF
mutations.
We report an informative patient with PPK, localized curly
hair, precocious puberty and a mosaic activating HRAS muta-
tion. This white male patient first presented aged 2 years4
with enlarged genitalia, pubic hair, accelerated growth, exten-
sive epidermal naevi and multiple melanocytic naevi. Endo-
crine investigations confirmed central precocious puberty with
adult levels of luteinizing hormone and testosterone. Comput-
erized tomography and contrast magnetic resonance imaging
of his brain at age 12 years showed no pituitary tumour or
any other intracranial anomaly. His medical and family history
were otherwise noncontributory.
Re-examination at age 33 years revealed an extensive Blas-
chkoid epidermal naevus affecting the face, neck and upper
torso (Fig. 1a–d). Some keratotic areas on the posterior neck,
in keeping with a sebaceous naevus, had been laser ablated. A
large papular naevus spilus on the left anterior torso partly
overlapped the epidermal naevus. On the forearms, papular
naevus spilus and epidermal naevi colocalized, while on the
right calf there was papular naevus spilus alone. The scalp hair
was brown with a striking Blaschkoid pattern of lighter,
shorter, wavy hair colocalizing with melanocytic naevi but no
apparent alopecia as typically seen in sebaceous naevus involv-
ing the scalp.
Following informed consent and ethics committee approval,
skin samples were taken from the neck where epidermal nae-
vus and papular naevus spilus overlapped and unaffected skin
from the lower back at the patient’s request, together with a
buccal swab and blood sample. DNA was extracted and tar-
geted deep sequencing performed for hotspots in BRAF, HRAS,
KRAS and NRAS. A rarely reported, activating mutation at codon
12 of HRAS (c.34G>C; p.Gly12Arg) was detected in affected
skin (30% mutant HRAS reads) and unaffected skin (5%
mutant HRAS reads) (mean coverage of 29000X); no other
changes were detected in the remaining targeted regions
(Fig. 1e). DNA from buccal mucosa did not display the muta-
tion using Sanger sequencing but deep sequencing revealed a
low percentage of mutant HRAS in saliva (9%) and blood
(4%).
Extracutaneous features in PPK typically affect neurological,
skeletal and endocrine systems. Hypophosphataemic rickets
due to cutaneous skeletal hypophosphataemia syndrome is
sometimes associated with verrucous epidermal naevi particu-
larly in the context of PPK and is attributed to fibroblast
growth factor (FGF)23 production by bone lesions not
detected in our patient. Precocious puberty, seen rarely in CS,5
is a recurrent finding in patients with PPK, occurring in eight
of 30 reported cases including ours (Table S1; see Supporting
Information). The only previous case of this association where
mutation analysis was performed showed a somatic BRAF
mutation (p.Lys601Asn).6
The HRAS mutation reported here was found not only in
affected skin but also in clinically normal tissues, a feature not
demonstrated in the four previous cases of PPK with extracuta-
neous features attributed to mosaic RASopathy.2,6 This dispar-
ity may reflect the greater sensitivity of the targeted
sequencing strategy we used and suggests that HRAS mutant
cells may occur in other, inaccessible organs such as the pitu-
itary gland. Given the association noted above of precocious
puberty with PPK and by implication with mosaic RASopathy,
a causal relationship seems likely. We suggest that pituitary
HRAS mosaicism disturbs cellular homeostasis in some way,
perhaps involving a second messenger analogous to HRAS-
induced FGF23, leading to central precocious puberty, but the
precise mechanism remains obscure. Taken together with the
report by Kuentz et al.,6 these cases strongly implicate Ras-Raf-
MEK-ERK signalling in the development of central precocious
puberty, with important therapeutic potential.
In conclusion, this unusual case demonstrates parallels
between PPK and CS reflecting, respectively, mosaic and germ-
line HRASopathy. We showed mutant HRAS DNA in the
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unaffected buccal mucosa and blood of a patient with PPK
with extracutaneous features. We confirmed an association of
PPK with precocious puberty. Finally, our observation offers
insight into the effects of Ras-Raf-MEK-ERK pathway activation
on pituitary function as well as the differential responses of
epidermal cell subpopulations.
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Fig 1. Clinical images of the patient aged
33 years and genetic analysis. (a,b) Head and
torso demonstrating linear and patchy lesions
of sebaceous naevus and patchy lesions of
papular naevus spilus, partly overlapping each
other. (c) Close-up of the neck revealing the
sebaceous naevus at this site of the epidermal
naevus. (d) Blaschkoid whorls are seen within
the scalp with lighter, wavy hair. (e) DNA
from the epidermal naevus but not buccal
mucosa appears to carry the HRAS c.34G>C
variant demonstrated by Sanger sequencing;
targeted next-generation sequencing reveals
mutant HRAS reads (visualized in Integrative
Genomics Viewer7) in the epidermal naevus,
as well as in unaffected skin, saliva and blood.
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Supporting Information
Additional Supporting Information may be found in the online
version of this article at the publisher’s website:
Table S1 Reported patients with phacomatosis pigmento-
keratotica and precocious puberty.
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